Sidransky D - Search Results

1

Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array.

Ahrendt SA, Halachmi S, Chow JT, Wu L, Halachmi N, Yang SC, Wehage S, Jen J, Sidransky D. Ahrendt SA, et al. Among authors: sidransky d. Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7382-7. doi: 10.1073/pnas.96.13.7382. Proc Natl Acad Sci U S A. 1999. PMID: 10377423 Free PMC article.

2

Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer.

Ahrendt SA, Chow JT, Xu LH, Yang SC, Eisenberger CF, Esteller M, Herman JG, Wu L, Decker PA, Jen J, Sidransky D. Ahrendt SA, et al. Among authors: sidransky d. J Natl Cancer Inst. 1999 Feb 17;91(4):332-9. doi: 10.1093/jnci/91.4.332. J Natl Cancer Inst. 1999. PMID: 10050866

3

The potential of molecular screening.

Ahrendt SA, Sidransky D. Ahrendt SA, et al. Among authors: sidransky d. Surg Oncol Clin N Am. 1999 Oct;8(4):641-56, vi. Surg Oncol Clin N Am. 1999. PMID: 10452932 Review.

4

Microsatellite instability at selected tetranucleotide repeats is associated with p53 mutations in non-small cell lung cancer.

Ahrendt SA, Decker PA, Doffek K, Wang B, Xu L, Demeure MJ, Jen J, Sidransky D. Ahrendt SA, et al. Among authors: sidransky d. Cancer Res. 2000 May 1;60(9):2488-91. Cancer Res. 2000. PMID: 10811129

5

Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer.

Ahrendt SA, Chow JT, Yang SC, Wu L, Zhang MJ, Jen J, Sidransky D. Ahrendt SA, et al. Among authors: sidransky d. Cancer Res. 2000 Jun 15;60(12):3155-9. Cancer Res. 2000. PMID: 10866304

6

p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer.

Ahrendt SA, Rashid A, Chow JT, Eisenberger CF, Pitt HA, Sidransky D. Ahrendt SA, et al. Among authors: sidransky d. J Hepatobiliary Pancreat Surg. 2000;7(4):426-31. doi: 10.1007/s005340070039. J Hepatobiliary Pancreat Surg. 2000. PMID: 11180865

7

O(6)-Methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer.

Wolf P, Hu YC, Doffek K, Sidransky D, Ahrendt SA. Wolf P, et al. Among authors: sidransky d. Cancer Res. 2001 Nov 15;61(22):8113-7. Cancer Res. 2001. PMID: 11719438

8

Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study.

Ahrendt SA, Yang SC, Wu L, Roig CM, Russell P, Westra WH, Jen J, Brock MV, Heitmiller RF, Sidransky D. Ahrendt SA, et al. Among authors: sidransky d. J Thorac Cardiovasc Surg. 2002 Mar;123(3):466-73; discussion 473-4. doi: 10.1067/mtc.2002.120343. J Thorac Cardiovasc Surg. 2002. PMID: 11882817 Free article.

9

Molecular detection approaches for smoking associated tumors.

Hu YC, Sidransky D, Ahrendt SA. Hu YC, et al. Among authors: sidransky d. Oncogene. 2002 Oct 21;21(48):7289-97. doi: 10.1038/sj.onc.1205805. Oncogene. 2002. PMID: 12379873 Review.

10

p53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective study.

Ahrendt SA, Hu Y, Buta M, McDermott MP, Benoit N, Yang SC, Wu L, Sidransky D. Ahrendt SA, et al. Among authors: sidransky d. J Natl Cancer Inst. 2003 Jul 2;95(13):961-70. doi: 10.1093/jnci/95.13.961. J Natl Cancer Inst. 2003. PMID: 12837832

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

593 results

Search Page

Filters